The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: Experience from a tertiary hospital.

CONCLUSION: IVB is a safe and effective first-line treatment for ROP and should be considered in resource-limited centres. PMID: 28281426 [PubMed - in process]
Source: South African Medical Journal - Category: African Health Tags: S Afr Med J Source Type: research